Talk:Disease-modifying antirheumatic drug

Other biologics
Here it lists only adalimumab and infliximab, but rheumatoid arthritis lists Rod57 (talk) 15:52, 25 November 2009 (UTC)
 * tumor necrosis factor alpha (TNFα) blockers - etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira)
 * Interleukin 1 (IL-1) blockers - anakinra (Kineret)
 * monoclonal antibodies against B cells - rituximab (Rituxan)[28]
 * T cell costimulation blocker - abatacept (Orencia)
 * Interleukin 6 (IL-6) blockers - tocilizumab (an anti-IL-6 receptor antibody) (RoActemra, Actemra)

Drug Mechanisms
The mechanisms should be referenced. The gold salts mechanism is proposed and hypothetical not confirmed. —Preceding unsigned comment added by 129.170.107.63 (talk) 02:44, 2 June 2010 (UTC)

Approved or investigational
Could we add to the members table the FDA approval date, and maybe in a separate table list investigational drugs in phase 3 clinical trials ? Rod57 (talk) 12:26, 10 November 2010 (UTC)